Stock analysts at Noble Financial raised their Q2 2026 earnings per share (EPS) estimates for AZZ in a research note issued ...

Stock analysts at Noble Financial issued their FY2024 earnings per share (EPS) estimates for Gyre Therapeutics in a research report issued to clients and investors on Tuesday, March 11th. Noble ...

In a report released today, Robert LeBoyer from Noble Financial reiterated a Buy rating on Cadrenal Therapeutics, Inc. (CVKD – Research ...

Noble Corporation plc ("Noble" or the "Company") (NYSE: NE) today announces plans to report financial results for the fourth quarter and full year 2024 on Monday February 17, 2025 after the U.S ...

We recently published an article titled These 10 Dividend Stocks are Underperforming in 2025. In this article, we are going ...

Barnes & Noble Education, Inc. announced its financial results for the third quarter of fiscal year 2025, showing a 2.1% increase in revenue to $466.3 million, primarily driven by a 21% year-over ...

What does this Advisor Specialize in? Find a financial advisor who specializes in the area of expertise you require. It's important to find an advisor who can help you approach your personal and ...

Barnes & Noble Education's business is highly seasonal, with the major portion of sales and operating profit realized during ...